"Material Safety Data Sheet of RIPA Buffer" In: "Sigma Aldrich Material Safety Data Sheet", (B1)

DUNCAN DIANE ET AL: "Injectable therapies for localized fat loss: state of the art.", CLINICS IN PLASTIC SURGERY JUL 2011 LNKD- PUBMED:21824545, vol. 38, no. 3, July 2011 (2011-07), pages 489-501 , VII, XP009153132, ISSN: 1558-0504 (B1)

FDA news release: "FDA issues warning letters fro drugs promoted in fat elimination procedure", , 7 April 2010 (2010-04-07), XP002661531, Retrieved from the Internet: URL:http://www.fda.gov/NewsEvents/Newsroom /PressAnnouncements/ucm207453.htm [retrieved on 2011-10-18] (B1)

Kythera Biopharmaceuticals: "Evaluation of safety and efficacy of ATX-101 in the reduction of submental fat", , 21 March 2011 (2011-03-21), XP002661530, Retrieved from the Internet: URL:http://clinicaltrials.gov/ct2/show/NCT 01305577 [retrieved on 2011-10-18] (B1)

[Online] Retrieved from the Internet: <URL:http://www.kytherabiopharma.com/newsro om/article/AAD_2013_Open-Label> (B1)

ROTUNDA A M ET AL: "Randomized double-blind clinical trial of subcutaneously injected deoxycholate versus a phosphatidylcholine-deoxycholate combination for the reduction of submental fat", DERMATOLOGIC SURGERY 2009 BLACKWELL PUBLISHING LTD GBR LNKD- DOI:10.1111/J.1524-4725.2009.01130.X, vol. 35, no. 5, 2009, pages 792-803, XP002661529, ISSN: 1076-0512 (B1)

Sigma: "RIFA Buffer", , September 2003 (2003-09), XP002661626, Retrieved from the Internet: URL:http://www.sigmaaldrich.com/etc/medial ib/docs/Sigma/Bulletin/r0278bul.Par.0001.F ile.tmp/r0278bul.pdf [retrieved on 2011-10-19] (B1)

US-A1- 2005 048 126 (B1)

US-B1- 6 417 179 (B1)

ROTUNDA A M ET AL: "Detergent effects of sodium deoxycholate are a major feature of an injectable phosphatidylcholine formulation used for localized fat dissolution", DERMATOLOGIC SURGERY, WILEY-BLACKWELL PUBLISHING, INC, NEW YORK, US, vol. 30, no. 7, 1 July 2004 (2004-07-01), pages 1001-1008, XP002331643, ISSN: 1076-0512, DOI: 10.1111/J.1524-4725.2004.30305.X (B1)